 |
Top 92 medical and healthcare startups in Boston
Last updated: May 13, 2024 |
1
Funding: $1.6B
Ginkgo Bioworks is the organism company. We design custom microbes for customers across multiple markets. We build our foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.
Ginkgo Bioworks is the organism company. We design custom microbes for customers across multiple markets. We build our foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.
2
Funding: $1B
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
3
Funding: $866M
Amwell is a telehealth platform that providers, insurers, patients, and innovators deliver more affordable, higher quality care.
Amwell is a telehealth platform that providers, insurers, patients, and innovators deliver more affordable, higher quality care.
4
Funding: $637M
Nimbus Therapeutics is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
Nimbus Therapeutics is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
5
Funding: $479.6M
Reify Health is a cloud-based software company that develops tools for the clinical trial ecosystem.
Reify Health is a cloud-based software company that develops tools for the clinical trial ecosystem.
6
Funding: $475M
Peerfit is a digital platform that’s helping insurance carriers, brokers and employers redefine corporate wellness programs.
Peerfit is a digital platform that’s helping insurance carriers, brokers and employers redefine corporate wellness programs.
7
Funding: $463.6M
Biofourmis is reinventing remote patient monitoring by detecting personalized patterns predictive of patient’s health deterioration
Biofourmis is reinventing remote patient monitoring by detecting personalized patterns predictive of patient’s health deterioration
8
Funding: $460M
Valo Health is a biotech company that is recreating the future of medicine. Valo is using computers to accelerate drug development while reducing the failure rate
Valo Health is a biotech company that is recreating the future of medicine. Valo is using computers to accelerate drug development while reducing the failure rate
9
Funding: $409M
Pear Therapeutics develops digital therapies to address a broad range of severe conditions including addiction, schizophrenia, pain, post-traumatic stress disorder, anxiety, depression, and sleep. PEAR’s eFormulationTM platform combines pharmaceutical preparations with user-friendly, customizable, and scientifically validated software applications. PEAR’s patented approach provides better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payors. Pear Therapeutics filed for bankruptcy
Pear Therapeutics develops digital therapies to address a broad range of severe conditions including addiction, schizophrenia, pain, post-traumatic stress disorder, anxiety, depression, and sleep. PEAR’s eFormulationTM platform combines pharmaceutical preparations with user-friendly, customizable, and scientifically validated software applications. PEAR’s patented approach provides better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payors. Pear Therapeutics filed for bankruptcy
10
Funding: $355.2M
PathAI's goal is to improve cancer diagnosis using artificial intelligence. PathAI’s services solve the most challenging pathology problems faced by the research and pharmaceutical industry.
PathAI's goal is to improve cancer diagnosis using artificial intelligence. PathAI’s services solve the most challenging pathology problems faced by the research and pharmaceutical industry.
11
Funding: $349.3M
Iora Health is a private healthcare company help patients manage their health and navigate the healthcare system.
Iora Health is a private healthcare company help patients manage their health and navigate the healthcare system.
12
Funding: $301.1M
Akili builds clinically-validated cognitive therapeutics, assessments, and diagnostics that look and feel like video games. It aims to develop a new type of electronic medicine that can be deployed remotely directly to any patient anywhere, prescribed and tracked by physicians, with the potential to be developed at a fraction of the cost of traditional medical approaches.
Akili builds clinically-validated cognitive therapeutics, assessments, and diagnostics that look and feel like video games. It aims to develop a new type of electronic medicine that can be deployed remotely directly to any patient anywhere, prescribed and tracked by physicians, with the potential to be developed at a fraction of the cost of traditional medical approaches.
13
Funding: $286.7M
Our pioneering, flexible diagnostic instrument and disposable cartridge system is designed for decentralised laboratory, point-of–care and other near-patient settings. It provides a fast, easy-to-use and accurate affordable solution to screening for the presence of STIs and HAIs, where rapid diagnosis is essential for effective treatment and control.
Our pioneering, flexible diagnostic instrument and disposable cartridge system is designed for decentralised laboratory, point-of–care and other near-patient settings. It provides a fast, easy-to-use and accurate affordable solution to screening for the presence of STIs and HAIs, where rapid diagnosis is essential for effective treatment and control.
14
Funding: $287M
Dewpoint Therapeutics is a biotech company which develop a drug platform that targets biomolecular condensates.
Dewpoint Therapeutics is a biotech company which develop a drug platform that targets biomolecular condensates.
15
Funding: $283.4M
Atea Pharmaceuticals is a biopharmaceutical company which is engaged in the acquisition, discovery and development of novel antiviral therapeutics.
Atea Pharmaceuticals is a biopharmaceutical company which is engaged in the acquisition, discovery and development of novel antiviral therapeutics.
16
Funding: $274.5M
Medically Home is a services company that supplies remote care technology for at-home acute care
Medically Home is a services company that supplies remote care technology for at-home acute care
17
Funding: $270M
Scorpion Therapeutics is a next-generation precision oncology company.
Scorpion Therapeutics is a next-generation precision oncology company.
18
Funding: $250.2M
Sophia Genetics aims to bring data analytics solutions to the market, to support healthcare professionals by maximizing the power of data-driven medicine. It achieves this mission through the adoption of SOPHiA AI, which is built using techniques such as statistical inference, pattern recognition, and machine learning.
Sophia Genetics aims to bring data analytics solutions to the market, to support healthcare professionals by maximizing the power of data-driven medicine. It achieves this mission through the adoption of SOPHiA AI, which is built using techniques such as statistical inference, pattern recognition, and machine learning.
19
Funding: $224M
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.
20
Funding: $224.3M
Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
21
Funding: $209M
Ikena Oncology is a biotechnology company that advances new immunometabolic therapies for cancer.
Ikena Oncology is a biotechnology company that advances new immunometabolic therapies for cancer.
22
Funding: $207.5M
Caresyntax is a digital surgery platform that uses proprietary software and AI to deliver actionable insights to improve patient outcomes.
Caresyntax is a digital surgery platform that uses proprietary software and AI to deliver actionable insights to improve patient outcomes.
23
Funding: $206.8M
Life Biosciences engages in advancing longevity research and entrepreneurial solutions to improve and extend healthy lives. We bring together scientists and investors to find innovative solutions and move them from the lab to the market to benefit all people.
Life Biosciences engages in advancing longevity research and entrepreneurial solutions to improve and extend healthy lives. We bring together scientists and investors to find innovative solutions and move them from the lab to the market to benefit all people.
24
Funding: $205M
Asimov programs living cells with genetic circuits. We partner with customers to create previously impossible biotechnologies.
Asimov programs living cells with genetic circuits. We partner with customers to create previously impossible biotechnologies.
25
Funding: $201.6M
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases such as Duchenne muscular dystrophy (DMD).
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases such as Duchenne muscular dystrophy (DMD).
26
Funding: $183.3M
Kyruus delivers search and scheduling solutions for health systems to match patients with the right providers across the access points.
Kyruus delivers search and scheduling solutions for health systems to match patients with the right providers across the access points.
27
Funding: $171M
OM1 is a leading healthcare technology company focused on providing outcomes measurement. We’ve built an intelligent data cloud to enable different healthcare stakeholders to cost-effectively access, analyze, and use outcomes data in a more robust, clinically meaningful, and precise way.
OM1 is a leading healthcare technology company focused on providing outcomes measurement. We’ve built an intelligent data cloud to enable different healthcare stakeholders to cost-effectively access, analyze, and use outcomes data in a more robust, clinically meaningful, and precise way.
28
Funding: $162.5M
Akouos is a new biotechnology company focused on restoring and preserving hearing.
Akouos is a new biotechnology company focused on restoring and preserving hearing.
29
Funding: $160M
Pieris Pharmaceuticals is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, inhaled Anticalin proteins to treat respiratory diseases, such as uncontrolled asthma, and a half-life-optimized Anticalin protein to treat anemia.
Pieris Pharmaceuticals is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, inhaled Anticalin proteins to treat respiratory diseases, such as uncontrolled asthma, and a half-life-optimized Anticalin protein to treat anemia.
30
Funding: $156M
Aktis Oncology develops radiopharmaceutical treatments for solid tumors.
Aktis Oncology develops radiopharmaceutical treatments for solid tumors.
31
Funding: $153M
PatientsLikeMe is a patient network and real-time research platform. Through the network, patients connect with others who have the same disease or condition and track and share their own experiences with the goal to improve outcomes.
PatientsLikeMe is a patient network and real-time research platform. Through the network, patients connect with others who have the same disease or condition and track and share their own experiences with the goal to improve outcomes.
32
Funding: $137.4M
Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. Yumanity is working to identify and develop new, disease-modifying therapies that address several illnesses with critical unmet medical needs. The initial focus of the company is neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. Yumanity is working to identify and develop new, disease-modifying therapies that address several illnesses with critical unmet medical needs. The initial focus of the company is neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
33
Funding: $129.7M
Elucid enables precision medicine for cardiovascular disease by applying A.I to medical image analysis validated against true biology.
Elucid enables precision medicine for cardiovascular disease by applying A.I to medical image analysis validated against true biology.
34
Funding: $115M
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. esTORbio’s lead program has demonstrated in several clinical trials, including a randomized, placebo-controlled trial, the potential to treat multiple diseases of aging for which there are no approved therapies.
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. esTORbio’s lead program has demonstrated in several clinical trials, including a randomized, placebo-controlled trial, the potential to treat multiple diseases of aging for which there are no approved therapies.
35
Funding: $115M
Author Health provides care and treatment for Medicare Advantage recipients with substance use disorders and serious mental illness.
Author Health provides care and treatment for Medicare Advantage recipients with substance use disorders and serious mental illness.
36
Funding: $110M
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing our proprietary RNA interference platform.
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing our proprietary RNA interference platform.
37
Funding: $109M
Nido Biosciences develops new precision medicines for neurological diseases and takes aim at Kennedy’s disease, a rare degenerative disorder.
Nido Biosciences develops new precision medicines for neurological diseases and takes aim at Kennedy’s disease, a rare degenerative disorder.
38
Funding: $101.2M
PatientPing helps us build better, stronger relationships with ACOs in the market,
PatientPing helps us build better, stronger relationships with ACOs in the market,
39
Funding: $100.4M
Activ Surgical is building a hardware-agnostic platform to enable autonomous and collaborative surgery through the integration of computer vision, artificial intelligence and robotics.
Activ Surgical is building a hardware-agnostic platform to enable autonomous and collaborative surgery through the integration of computer vision, artificial intelligence and robotics.
40
Funding: $96.1M
Cohere Health is changing the way patients, physicians and health plans work together. Our collaboration platform improves patient and physician experience, increases quality and reduces total cost of care.
Cohere Health is changing the way patients, physicians and health plans work together. Our collaboration platform improves patient and physician experience, increases quality and reduces total cost of care.
41
Funding: $95M
CodaMetrix is building an AI-powered platform for healthcare revenue cycle management
CodaMetrix is building an AI-powered platform for healthcare revenue cycle management
42
Funding: $93.2M
Snap40 develops a device that monitors users via its single medical-grade wearable device, worn on the upper arm. This includes relative changes in systolic blood pressure, respiratory rate, heart rate, mobility, blood oxygen saturation, and temperature, as well as perspiration and movement levels.
Snap40 develops a device that monitors users via its single medical-grade wearable device, worn on the upper arm. This includes relative changes in systolic blood pressure, respiratory rate, heart rate, mobility, blood oxygen saturation, and temperature, as well as perspiration and movement levels.
43
Funding: $93.2M
The primary device of Current’s monitoring platform is an FDA-cleared upper-arm wearable that tracks skin temperature, pulse rate, oxygen saturation, movement and other metrics. It uses AI for precise early warning alerts.
The primary device of Current’s monitoring platform is an FDA-cleared upper-arm wearable that tracks skin temperature, pulse rate, oxygen saturation, movement and other metrics. It uses AI for precise early warning alerts.
44
Funding: $90M
Ascidian Therapeutics is a biotechnology company intended for medical use in medical and clinical gene therapy.
Ascidian Therapeutics is a biotechnology company intended for medical use in medical and clinical gene therapy.
45
Funding: $88.7M
Zoe is leading the world’s largest ongoing nutritional research project in collaboration with scientists from universities including Harvard, King's College London, Massachusetts General Hospital, Oxford and Stanford.
Zoe is leading the world’s largest ongoing nutritional research project in collaboration with scientists from universities including Harvard, King's College London, Massachusetts General Hospital, Oxford and Stanford.
46
Funding: $82.3M
Renovia is the maker of an FDA-cleared, app-based system for pelvic floor disorder management and therapy
Renovia is the maker of an FDA-cleared, app-based system for pelvic floor disorder management and therapy
47
Funding: $76.2M
Recent scientific breakthroughs are revolutionizing the way we think about DNA and health. Orig3n is on a mission to turn these discoveries into practical solutions and make them available to you.
Recent scientific breakthroughs are revolutionizing the way we think about DNA and health. Orig3n is on a mission to turn these discoveries into practical solutions and make them available to you.
48
Funding: $75.5M
1upHealth is a platform for patients, providers, and app developers to aggregate and share medical data and wearable device metrics.
1upHealth is a platform for patients, providers, and app developers to aggregate and share medical data and wearable device metrics.
49
Funding: $75M
OncoMyx Therapeutics develops oncolytic immunotherapies to orchestrate an immune response and treat cancer.
OncoMyx Therapeutics develops oncolytic immunotherapies to orchestrate an immune response and treat cancer.
